FindTrial
Sign In

Association of liver disease with obesity in people having diabetics.

Prevalance of non-alcoholic fatty liver disease in obese and non-obese diabetics-a comparative study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/06/019672
Enrollment
104
Registered
2019-06-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified Health Condition 2: E669- Obesity, unspecified Health Condition 3: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

None listed

Sponsors

Batra Hospital and Medical Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Type 2 Diabetes

Exclusion criteria

Exclusion criteria: 1) History of alcohol intake (more than 20 gms in per day in males and more then 10 gms per day in females). 2) Chronic liver disease like Hepatitis C and Hepatitis B, Autoimmune hepatitis. 3) History of taking drugs known to cause fatty liver disease E.g. Amidarone, tamoxifen, Glucocorticoids, Esterogens. 4) Recent and past illness known to cause NAFLD like protein energy malnutrition, starvation, patient on Total parenternal nutrition , Gastrointestinal surgery for obesity, inflammatory bowel disease, Wilson disease .

Design outcomes

Primary

MeasureTime frame
Prevalence of NAFLD in patients of type2 diabetes mellitus.Timepoint: 1 Day—

Secondary

MeasureTime frame
Association between obesity and NAFLD in diabeticsTimepoint: 1 Day—

Countries

India

Contacts

Public ContactDr Shashank Bhardwaj

Batra Hospital and Medical Research Centre

juhidhar24@gmail.com8920744429

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026